Anti-cancer pioneers

March 9, 2007

Two Dundee University mathematicians have been awarded £160,000 by the Engineering and Physical Sciences Research Council to develop a new breed of "targeted" anti-cancer drugs. Fordyce Davidson and Mark Chaplain will work with biotechnology company Cyclacel Pharmaceuticals Inc.

Register to continue

Why register?

  • Registration is free and only takes a moment
  • Once registered, you can read 3 articles a month
  • Sign up for our newsletter
Register
Please Login or Register to read this article.

Sponsored

Featured jobs